InvestorsHub Logo
Followers 177
Posts 11263
Boards Moderated 0
Alias Born 04/04/2011

Re: RobinIV post# 6681

Thursday, 02/06/2014 11:22:13 AM

Thursday, February 06, 2014 11:22:13 AM

Post# of 27076
Of course I will ask him AGAIN about when he thinks they will become cash flow positive, but he most likely answer as he has before by stating it is his goal to get cash flow positive as soon as possible, as it is their main goal and focus. However, I will try to see what this new deal could mean for them this year in terms of producing revenue and contributing to their goal of becoming cash flow positive. If you think he will give me a specific time frame, it won't happen. Mr. James has made a clear from the onset that he will not state something that he can't be absolutely certain about. In other words, unlike so many others in the OTC market, he will not make any projections until he is absolutely certain of it. I applaud him for taking that stance, because the OTC market is filled with CEO's making big bold projections that never come to fruition. Thus I don't want you expecting him to give a specific time frame about when they will become cash flow positive at this point, because he won't do it until he is absolutely certain and doubt he can be certain at this point. I do think they will get there this year and that is what I will focus on and ask him about.

FYI - Setting the record straight isn't rattling on and looks like you are now focused on the share price with your statement about the pps dropping 20%.

Moving forward, I think the share price will continue to fluctuate for awhile as it consolidates. I think $.12 should be strong support for the stock right now. Once the swing traders are done selling, the stock will start making a more gradual upward trend. Those going the stock will be the most rewarded in the end IMHO.

Cheers!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.